IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma

AIM: The study was designed to mine the expression and roles of IQGAP3 in clear cell renal cell carcinoma (ccRCC). METHODS: Expression profiles and clinical information were obtained from the Cancer Genome Atlas (TCGA) to estimate IQGAP3 expression in ccRCC, its relationship with patients’ clinicopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Quan, Li, Can-Xuan, Long, Dan, Lin, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286744/
https://www.ncbi.nlm.nih.gov/pubmed/34285569
http://dx.doi.org/10.2147/IJGM.S316280
Descripción
Sumario:AIM: The study was designed to mine the expression and roles of IQGAP3 in clear cell renal cell carcinoma (ccRCC). METHODS: Expression profiles and clinical information were obtained from the Cancer Genome Atlas (TCGA) to estimate IQGAP3 expression in ccRCC, its relationship with patients’ clinicopathological variables and prognosis, and the potential biological mechanisms. RESULTS: IQGAP3 was highly expressed in ccRCC and indicated advanced clinical outcome and poor prognosis. IQGAP3 affected the progression of ccRCC through several cancer-related pathways. IQGAP3 might play a vital role in the ccRCC tumor microenvironment. CONCLUSION: IQGAP3 could serve as a promising prognostic biomarker and therapeutic target.

Ejemplares similares